ANKRD20A1
Ankyrin repeat domain-containing protein 20A1
Also known as: A20A1_HUMAN, ANKRD20A, DKFZp434A171
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TYW2
- Gene
- ANKRD20A1
- Ensembl
- ENSG00000260691
- Chromosome
- 9
- Canonical length
- 823 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
823 residues, UniProt reviewed canonical sequence.
>Q5TYW2|ANKRD20A1
1 MKLFGFGSRR GQTAQGSIDH VYTGSGYRIR DSELQKIHRA AVKGDAAEVE RCLARRSGDL
61 DALDKQHRTA LHLACTSGHV QVVTLLVNRK CQIDVCDKEN RTPLIQAVHC QEEACAVILL
121 EHGANPNLKD IYGNTALHYA VYSESTSLAE KLLSHGAHIE ALDKDNNTPL LFAIICKKEK
181 MVEFLLKKKA SSHAVDRLRR SALMLAVYYD SPGIVNILLK QNIDVFAQDM CGRDAEDYAI
241 SHHLTKIQQQ ILEHKKKILK KEKSDVGSSD ESAVSIFHEL RVDSLPASDD KDLNVATKQC
301 VPEKVSEPLP GSSHEKGNRI VNGQGEGPPA KHPSLKPSTE VEDPAVKGAV QRKNVQTLRA
361 EQALPVASEE EQERHERSEK KQPQVKEGNN TNKSEKIQLS ENICDSTSSA AAGRLTQQRK
421 IGKTYPQQFP KKLKEEHDRC TLKQENEEKT NVNMLYKKNR EELERKEKQY KKEVEAKQLE
481 PTVQSLEMKS KTARNTPNWD FHNHEEMKGL MDENCILKAD IAILRQEICT MKNDNLEKEN
541 KYLKDIKIVK ETNAALEKYI KLNEEMITET AFRYQQELND LKAENTRLNA ELLKEKESKK
601 RLEADIESYQ SRLAAAISKH SESVKTERNL KLALERTRDV SVQVEMSSAI SKVKAENEFL
661 TEQLSETQIK FNALKDKFRK TRDSLRKKSL ALETVQNDLS QTQQQTQEMK EMYQNAEAKV
721 NNSTGKWNCV EERICHLQRE NAWLVQQLDD VHQKEDHKEI VTNIQRGFIE SGKKDLVLEE
781 KSKKLMNECD HLKESLFQYE REKTEGVVSI KEDKYFQTSR KTILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANKRD20A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 3.9 nTPM
Expression across tissuesHPA
Tissue
- testis: 3.9 nTPM
- heart muscle: 1.1 nTPM
- pancreas: 1.1 nTPM
- spleen: 1 nTPM
- placenta: 0.9 nTPM
- adipose tissue: 0.7 nTPM
Single-cell type
- undifferentiated spermatogonia: 62 nCPM
- early primary spermatocytes: 25 nCPM
- differentiating spermatogonia: 14 nCPM
- oligodendrocyte progenitor cells: 12 nCPM
- late primary spermatocytes: 7.3 nCPM
- epididymal efferent duct absorptive cells: 6.9 nCPM
Immune cell
- plasmacytoid DC: 0.2 nTPM
- eosinophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 15 nTPM
- hypothalamus: 15 nTPM
- cerebral cortex: 15 nTPM
- hippocampal formation: 13 nTPM
- pons: 13 nTPM
- white matter: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANKRD20A1 as an antibody target. Whether an autoantibody or antibody against ANKRD20A1 could matter depends on whether native ANKRD20A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANKRD20A1 is annotated at the cell surface, where native ANKRD20A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ANKRD20A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...